SIGA Technologies Inc (SIGA) - Total Liabilities
Based on the latest financial reports, SIGA Technologies Inc (SIGA) has total liabilities worth $67.77 Trillion USD as of March 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Check SIGA financial resilience to evaluate the company's liquid asset resilience ratio.
SIGA Technologies Inc - Total Liabilities Trend (1996–2025)
This chart illustrates how SIGA Technologies Inc's total liabilities have evolved over time, based on quarterly financial data. For the complete balance sheet picture, see SIGA total asset value.
SIGA Technologies Inc Competitors by Total Liabilities
The table below lists competitors of SIGA Technologies Inc ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
INFINITT Healthcare Co. Ltd
KQ:071200
|
Korea | ₩48.26 Billion |
|
SNS
KLSE:0259
|
Malaysia | RM352.73 Million |
|
Unique Optical Industrial Co Ltd
TWO:3441
|
Taiwan | NT$306.45 Million |
|
Millennial Potash Corp.
V:MLP
|
Canada | CA$1.39 Million |
|
Agilyx AS
OL:AGLX
|
Norway | Nkr50.81 Million |
|
Azkoyen
MC:AZK
|
Spain | €71.89 Million |
|
Young Fast Optoelectronics Co Ltd
TW:3622
|
Taiwan | NT$1.29 Billion |
|
Solar A/S
CO:SOLAR-B
|
Denmark | Dkr4.30 Billion |
Liability Composition Analysis (1996–2025)
This chart breaks down SIGA Technologies Inc's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. See SIGA Technologies Inc (SIGA) balance sheet quality index to measure how much of total assets are equity-financed.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 3.25 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.45 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.31 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how SIGA Technologies Inc's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for SIGA Technologies Inc (1996–2025)
The table below shows the annual total liabilities of SIGA Technologies Inc from 1996 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-12-31 | $20.65 Million | -27.64% |
| 2024-12-31 | $28.53 Million | -50.37% |
| 2023-12-31 | $57.49 Million | +131.12% |
| 2022-12-31 | $24.88 Million | -38.44% |
| 2021-12-31 | $40.41 Million | +101.68% |
| 2020-12-31 | $20.04 Million | -80.12% |
| 2019-12-31 | $100.78 Million | +0.25% |
| 2018-12-31 | $100.53 Million | -78.51% |
| 2017-12-31 | $467.81 Million | +4.33% |
| 2016-12-31 | $448.40 Million | -4.63% |
| 2015-12-31 | $470.16 Million | +13.87% |
| 2014-12-31 | $412.89 Million | +133.47% |
| 2013-12-31 | $176.85 Million | +130.00% |
| 2012-12-31 | $76.89 Million | +57.90% |
| 2011-12-31 | $48.69 Million | +225.43% |
| 2010-12-31 | $14.96 Million | -3.01% |
| 2009-12-31 | $15.43 Million | +113.00% |
| 2008-12-31 | $7.24 Million | +35.11% |
| 2007-12-31 | $5.36 Million | -20.54% |
| 2006-12-31 | $6.75 Million | +134.72% |
| 2005-12-31 | $2.87 Million | +85.26% |
| 2004-12-31 | $1.55 Million | +182.97% |
| 2003-12-31 | $548.23K | -16.54% |
| 2002-12-31 | $656.91K | -1.40% |
| 2001-12-31 | $666.20K | -70.85% |
| 2000-12-31 | $2.29 Million | +90.45% |
| 1999-12-31 | $1.20 Million | -20.00% |
| 1998-12-31 | $1.50 Million | +200.00% |
| 1997-12-31 | $500.00K | +150.00% |
| 1996-12-31 | $200.00K | -- |
About SIGA Technologies Inc
SIGA Technologies, Inc., a commercial-stage pharmaceutical company, focuses on the health security market in the United States. The company's lead product is TPOXX, an antiviral drug for the treatment of human smallpox disease caused by variola virus. SIGA Technologies, Inc. was incorporated in 1995 and is headquartered in New York, New York.